163 related articles for article (PubMed ID: 36810359)
1. Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis.
Kwon OC; Park MC
Sci Rep; 2023 Feb; 13(1):3068. PubMed ID: 36810359
[TBL] [Abstract][Full Text] [Related]
2. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
Ho A; Magder LS; Barr SG; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
[TBL] [Abstract][Full Text] [Related]
3. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
4. Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.
van den Berg L; Nossent H; Rekvig O
Clin Rheumatol; 2006 May; 25(3):347-52. PubMed ID: 16328091
[TBL] [Abstract][Full Text] [Related]
5. SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.
Yeo AL; Kandane-Rathnayake R; Koelmeyer R; Golder V; Louthrenoo W; Chen YH; Cho J; Lateef A; Hamijoyo L; Luo SF; Wu YJ; Navarra SV; Zamora L; Li Z; An Y; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake BMDB; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Lau CS; Nikpour M; Hoi A; Leech M; Morand EF;
Rheumatology (Oxford); 2024 Feb; 63(2):525-533. PubMed ID: 37208196
[TBL] [Abstract][Full Text] [Related]
6. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
[TBL] [Abstract][Full Text] [Related]
7. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
8. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
9. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus.
Bao S; Huang H; Jin Y; Ding F; Yang Z; Xu X; Liu C; Lu J; Jin Y
Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37012058
[TBL] [Abstract][Full Text] [Related]
11. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity.
Sun F; Zhao L; Wang H; Zhang D; Chen J; Wang X; Li T; Ye S
Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35606018
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
14. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
15. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus.
Ramos PS; Kelly JA; Gray-McGuire C; Bruner GR; Leiran AN; Meyer CM; Namjou B; Espe KJ; Ortmann WA; Reichlin M; Langefeld CD; James JA; Gaffney PM; Behrens TW; Harley JB; Moser KL
Genes Immun; 2006 Jul; 7(5):417-32. PubMed ID: 16775618
[TBL] [Abstract][Full Text] [Related]
16. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review.
Floris A; Piga M; Cauli A; Mathieu A
Autoimmun Rev; 2016 Jul; 15(7):656-63. PubMed ID: 26921641
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
18. The homogeneous multiplexed system--a new method for autoantibody profile in systemic lupus erythematosus.
Zandman-Goddard G; Gilburd B; Shovman O; Blank M; Berdichevski S; Langevitz P; Shoenfeld Y
Clin Dev Immunol; 2005 Jun; 12(2):107-11. PubMed ID: 16050141
[TBL] [Abstract][Full Text] [Related]
19. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Choi MY; Chen I; Clarke AE; Fritzler MJ; Buhler KA; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Sontag D; Costenbader KH
Ann Rheum Dis; 2023 Jul; 82(7):927-936. PubMed ID: 37085289
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Anti-dsDNA Tests by Indirect Immunofluorescence and Enzyme-linked Immunosorbent Assay in Patients with Systemic Lupus Erythematosus.
Nieto-Aristizábal I; España LJ; Ortega J; Ruiz-Ordoñez I; Vivas ÁJ; Castaño GL; Castillo C; Bautista-Vargas M; Suárez A; Cañas CA; Tobón GJ
J Appl Lab Med; 2023 Jul; 8(4):713-725. PubMed ID: 37018046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
